Mouse liver tumors and microsomal enzyme-inducing drugs: experimental and clinical perspectives with phenobarbital.
McClain
R M
RM
Department of Toxicology and Pathology, Hoffmann-La Roche Inc., Nutley, NJ 07110.
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000453:epidemiology; D002450:Cell Communication / Q000187:drug effects; D003043:Cocarcinogenesis; D004249:DNA Damage; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D009152:Mutagenicity Tests; D010634:Phenobarbital / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity*; D051381:Rats; D011916:Rats, Inbred F344; D011919:Rats, Inbred Strains; D012737:Sex Factors
D010634:Phenobarbital